Lupin, an Indian pharmaceutical company, has announced a strategic collaboration with Enzene Biosciences, a subsidiary of Alkem Laboratories, to introduce Cetuximab in India. Cetuximab is the first biosimilar developed for Eli Lilly and Company’s Cetuximab, a monoclonal antibody medication used in the treatment of various types of cancer, including head and neck cancer and metastatic […]
Themis Medicare has been granted approval from the Drug Controller General of India (DCGI) for importing and commercialization of Remifentanil 1 mg/2mg Powder for Concentrate for Solution for Injection under the brand name REMITHEM. The drug has been authorized to be used as an analgesic medication for the induction and maintenance of general anesthesia during […]
Zydus Cadila (Cadila Healthcare) said that it has secured the emergency use authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D vaccine for Covid-19 for adults and also adolescents in the age group of 12-18 years. According to Zydus Cadila, ZyCoV-D is the first Plasmid DNA vaccine for Covid-19 in the world. […]
Zydus Cadila has secured restricted emergency use approval for ‘Virafin’, Pegylated Interferon alpha-2b (PegIFN) from the Drug Controller General of India (DCGI) for the treatment of moderate Covid-19 infection in adult patients. According to the Indian pharma company, a single dose subcutaneous regimen of Virafin will make the treatment more easier for the patients. When […]
The Russian Direct Investment Fund (RDIF) has announced that the Sputnik V Covid-19 vaccine has been approved for use in India by the Drug Controller General of India (DCGI). India is now the 60th country to have approved the Sputnik V vaccine for giving protection against the novel coronavirus, said the Russian sovereign wealth fund. […]
Dr. Reddy’s Laboratories has secured permission from the Drug Controller General of India (DCGI) for importing the Sputnik V vaccine into India under emergency use authorization (EUA). In February 2021, Dr. Reddy’s Laboratories commenced the process to seek the emergency use authorization for the Russian Covid-19 vaccine from the Indian drug regulator. Last September 2020, […]
Glenmark Pharmaceuticals has secured approval from India to launch Japan-based Fujifilm’s antiviral drug favipiravir under the brand name FabiFlu for the treatment of COVID-19 in patients with mild to moderate symptoms. The Indian pharma company has been granted manufacturing and marketing approval from the Drug Controller General of India (DCGI), a department of the Central […]